CAI
Price
$31.71
Change
-$0.64 (-1.98%)
Updated
Oct 22 closing price
Capitalization
8.96B
13 days until earnings call
Intraday BUY SELL Signals
TWST
Price
$135.47
Change
-$13.66 (-9.16%)
Updated
Oct 22 closing price
Capitalization
8.98B
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CAI vs TWST

CAI vs TWST Comparison Chart in %
View a ticker or compare two or three
VS
CAI vs. TWST commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAI is a StrongBuy and TWST is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CAI with price predictions
Oct 22, 2026

CAI in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 06, 2026

CAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 8 of 10 cases where CAI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on CAI as a result. In 22 of 30 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for CAI just turned positive on October 21, 2026. Looking at past instances where CAI's MACD turned positive, the stock continued to rise in 7 of 10 cases over the following month. The odds of a continued upward trend are 70%.

Following a +5.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CAI advanced for three days, in 45 of 65 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 28 of 50 cases where CAI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.

Bearish Trend Analysis

The 10-day RSI Indicator for CAI moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 similar instances where the indicator moved out of overbought territory. In 5 of the 6 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CAI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.144) is normal, around the industry mean (2.973). P/E Ratio (3.310) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (9.059). Dividend Yield (0.021) settles around the average of (128.121) among similar stocks. P/S Ratio (8.084) is also within normal values, averaging (438.009).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TWST with price predictions
Oct 22, 2026

TWST sees MACD Histogram crosses below signal line

TWST saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 07, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 41 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for TWST moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In 37 of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.

The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TWST as a result. In 64 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

TWST moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TWST crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TWST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

TWST broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 63 cases where TWST's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

Following a +6.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where TWST advanced for three days, in 235 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 188 of 228 cases where TWST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.150) is normal, around the industry mean (2.973). TWST has a moderately low P/E Ratio (-60.749) as compared to the industry average of (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (20.243) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. TWST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 86 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TWST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
CAI vs TWST: Fundamental Ratings
CAI
TWST
OUTLOOK RATING
1..100
271
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
4697
PRICE GROWTH RATING
1..100
3534
P/E GROWTH RATING
1..100
491
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (4) in the Biotechnology industry is significantly better than the same rating for CAI (86) in the Finance Or Rental Or Leasing industry. This means that TWST’s stock grew significantly faster than CAI’s over the last 12 months.

TWST's Profit vs Risk Rating (86) in the Biotechnology industry is in the same range as CAI (100) in the Finance Or Rental Or Leasing industry. This means that TWST’s stock grew similarly to CAI’s over the last 12 months.

CAI's SMR Rating (46) in the Finance Or Rental Or Leasing industry is somewhat better than the same rating for TWST (97) in the Biotechnology industry. This means that CAI’s stock grew somewhat faster than TWST’s over the last 12 months.

TWST's Price Growth Rating (34) in the Biotechnology industry is in the same range as CAI (35) in the Finance Or Rental Or Leasing industry. This means that TWST’s stock grew similarly to CAI’s over the last 12 months.

CAI's P/E Growth Rating (4) in the Finance Or Rental Or Leasing industry is significantly better than the same rating for TWST (91) in the Biotechnology industry. This means that CAI’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAITWST
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
11%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
77%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CAI: $32.35 vs. TWST: $135.47)
Brand notoriety: CAI and TWST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAI: 47% vs. TWST: 118%
Market capitalization -- CAI: $8.96B vs. TWST: $8.98B
CAI [@Biotechnology] is valued at $8.96B. TWST’s [@Biotechnology] market capitalization is $8.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAI’s FA Score shows that 1 FA rating(s) are green while TWST’s FA Score has 1 green FA rating(s).

  • CAI’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 1 green, 4 red.
According to our system of comparison, CAI is a better buy in the long-term than TWST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAI’s TA Score shows that 5 TA indicator(s) are bullish while TWST’s TA Score has 3 bullish TA indicator(s).

  • CAI’s TA Score: 5 bullish, 3 bearish.
  • TWST’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CAI is a better buy in the short-term than TWST.

Price Growth

CAI (@Biotechnology) experienced а +6.92% price change this week, while TWST (@Biotechnology) price change was -6.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

CAI is expected to report earnings on Nov 04, 2026.

TWST is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CAI
Daily Signal:
Gain/Loss:
TWST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
-1.98%
BMEA - CAI
38%
Loosely correlated
-15.23%
TWST - CAI
37%
Loosely correlated
-9.16%
RXRX - CAI
36%
Loosely correlated
-1.65%
GMAB - CAI
33%
Loosely correlated
+1.09%
ABCL - CAI
33%
Poorly correlated
-7.11%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
INKM33.860.20
+0.61%
State Street Income Allocation ETF (INKM)
NBCE34.37N/A
N/A
Neuberger China Equity ETF (NBCE)
PFEB44.22-0.19
-0.43%
Innovator U.S. Equity Power Buffer ETF - February (PFEB)
EFV79.06-0.36
-0.45%
iShares MSCI EAFE Value ETF (EFV)
FCTE29.54-0.20
-0.68%
SMI 3Fourteen Full-Cycle Trend ETF (FCTE)